In a study by Wang et al. [51], increased CD47 expression levels correlated with higher recurrence rates and elevated EBV-DNA levels in non-metastatic NPC, mirroring the findings of our research. The gene discussed is CD47; the disease is nasopharyngeal carcinoma.